UroGen Pharma Ltd
URGN
27.65
-4.08
-12.86%
UroGen Pharma Ltd
US · URGN
#2773 by market cap
Listed 2017
27.65
-4.08
-12.86%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 5 analysts
Buy
Avg price target 62.20 +125.0%
Price target rangecurrent 27.65
Low56.00
Avg62.20
High75.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-05 | Piper Sandler | -- | Buy | 58.00 |
| 2026-11-05 | Ladenburg Thalmann | -- | Buy | 62.00 |
| 2026-11-05 | H.C. Wainwright | -- | Buy | 75.00 |
| 2026-11-05 | Oppenheimer | -- | Buy | 60.00 |
| 2026-11-04 | Guggenheim | -- | Buy | 56.00 |
| 2026-11-03 | H.C. Wainwright | -- | Buy | 75.00 |
| 2026-10-28 | Oppenheimer | -- | Buy | 60.00 |
| 2026-10-19 | Guggenheim | -- | Buy | 58.00 |
| 2026-10-19 | H.C. Wainwright | -- | Buy | 75.00 |
| 2026-08-21 | H.C. Wainwright | -- | Buy | 75.00 |
| 2026-08-20 | H.C. Wainwright | -- | Buy | 75.00 |
| 2026-08-11 | H.C. Wainwright | -- | Buy | 75.00 |
| 2026-08-06 | H.C. Wainwright | -- | Buy | 75.00 |
| 2026-08-06 | Oppenheimer | -- | Buy | 60.00 |
| 2026-08-05 | TD Cowen | -- | Buy | 60.00 |
| 2026-08-05 | Goldman Sachs | -- | Hold | 48.00 |
| 2026-08-05 | Guggenheim | -- | Buy | 58.00 |
| 2026-07-21 | Guggenheim | -- | Buy | 42.00 |
| 2026-07-20 | TD Cowen | -- | Buy | 50.00 |
| 2026-07-16 | H.C. Wainwright | -- | Buy | 45.00 |
| 2026-07-16 | Oppenheimer | -- | Buy | 50.00 |
| 2026-07-15 | Goldman Sachs | -- | Hold | 44.00 |
| 2026-07-09 | H.C. Wainwright | -- | Buy | 45.00 |
| 2026-06-16 | TD Cowen | -- | Buy | 35.00 |
| 2026-06-03 | H.C. Wainwright | -- | Buy | 45.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-04 | -- | ±15.78% | -16.45% (beat) |
| 2026/Q2 | 2026-08-05 | -- | ±16.78% | +16.31% (in line) |
| 2026/Q1 | 2026-05-06 | -- | ±16.51% | +10.16% (in line) |
| 2025/Q4 | 2026-03-02 | -- | ±19.22% | -12.35% (in line) |
| 2025/Q3 | 2025-11-06 | -- | ±29.01% | +21.91% (in line) |
| 2025/Q2 | 2025-08-07 | -- | ±13.32% | -7.10% (in line) |
| 2025/Q1 | 2025-05-12 | -- | ±25.06% | +7.32% (in line) |
| 2024/Q4 | 2025-03-10 | -- | ±18.71% | +1.02% (in line) |
| 2024/Q3 | 2024-11-06 | -- | ±14.91% | +0.25% (in line) |
| 2024/Q2 | 2024-08-13 | -- | ±19.85% | +3.10% (in line) |
| 2024/Q1 | 2024-05-13 | -- | ±17.20% | +2.59% (in line) |
| 2023/Q4 | 2024-03-14 | -- | ±12.82% | -17.97% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.
UroGen Pharma Ltd discussion 0 comments